|
Volumn 2, Issue 7, 2014, Pages e9-e10
|
Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality
|
Author keywords
[No Author keywords available]
|
Indexed keywords
SIALIDASE INHIBITOR;
ANTIVIRUS AGENT;
ENZYME INHIBITOR;
OSELTAMIVIR;
SIALIDASE;
ZANAMIVIR;
DRUG EFFICACY;
DRUG EXPOSURE;
DRUG USE;
GOVERNMENT;
HOSPITAL ADMISSION;
HUMAN;
IMMUNE RESPONSE;
LETTER;
MORTALITY;
OUTCOME ASSESSMENT;
PANDEMIC INFLUENZA;
PRIORITY JOURNAL;
PUBLIC HEALTH;
RISK ASSESSMENT;
STATISTICAL ANALYSIS;
ANTAGONISTS AND INHIBITORS;
FEMALE;
INFLUENZA VIRUS A H1N1;
INFLUENZA, HUMAN;
MALE;
PANDEMIC;
ANTIVIRAL AGENTS;
ENZYME INHIBITORS;
FEMALE;
HUMANS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA, HUMAN;
MALE;
NEURAMINIDASE;
OSELTAMIVIR;
PANDEMICS;
ZANAMIVIR;
|
EID: 84903943315
PISSN: 22132600
EISSN: 22132619
Source Type: Journal
DOI: 10.1016/S2213-2600(14)70126-2 Document Type: Letter |
Times cited : (9)
|
References (5)
|